POM-V Prescription Required

Gallimune 407 ND + IB + EDS + ART

Active ingredients: Avian pneumovirus, Egg drop syndrome virus, Infectious bronchitis virus, Newcastle disease virus

Form

Injection

Species

Chickens

Manufacturer

Boehringer Ingelheim Vetmedica GmbH

VMD MA No.

04491/3016

What it's used for

Active immunisation of breeder and layer pullets in order to reduce egg drop linked to infection with egg drop syndrome virus (EDS76) without priming. Newc...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Avian pneumovirus + Egg drop...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Gallimune 407 ND + IB + EDS + ART — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Active immunisation of breeder and layer pullets in order to reduce egg drop linked to
infection with egg drop syndrome virus (EDS76) without priming.
Newcastle disease, infectious bronchitis and egg drop syndrome components:
- Onset of immunity: 4 weeks after vaccination,
- Duration of immunity: one laying period.
Turkey rhinotracheitis component:
- Onset of immunity: 14 weeks after vaccination.
- Duration of immunity: one laying period.

4 weeks after the priming with live vaccines against Newcastle disease (strain Hitchner B1
or VG/GA-AVINEW), infectious bronchitis (strain Mass H120), and avian pneumovirus
(strain PL21).
Shake well before use.
Apply usual aseptic procedures.
Do not use syringes with natural rubber or butyl elastomer pistons.
Equipment including needles and syringes must be sterile before use.

None.

Chickens:
Very common
(> 1 animal / 10 animals treated):
Abnormal histology.
1
At the injection site. Lesions linked to the oily adjuvant were histologically observed in
87% of cases three weeks after injection, e.g. small quantities of oily residues and
occasional aseptic micro-abscesses. No palpable reactions were observed.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
To the user:
This veterinary medicinal product contains mineral oil. Accidental injection/self-injection
may result in severe pain and swelling, particularly if injected into a joint or finger, and in
rare cases could result in the loss of the affected finger if prompt medical attention is not
given. If you are accidentally injected with this veterinary medicinal product, seek prompt
medical advice even if only a very small amount is injected and take the package leaflet
with you. If pain persists for more than 12 hours after medical examination, seek medical
advice again.
To the physician:
This veterinary medicinal product contains mineral oil. Even if small amounts have been
injected, accidental injection with this veterinary medicinal product can cause intense
swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit.
Expert, PROMPT, surgical attention is required and may necessitate early incision and
irrigation of the injected area, especially where there is involvement of finger pulp or
tendon.
Special precautions for the protection of the environment:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with any
other veterinary medicinal product. A decision to use this vaccine before or after any other
veterinary medicinal product therefore needs to be made on a case by case basis.

Store and transport refrigerated (2 °C – 8 °C).
Do not freeze.
Protect from light.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.